Drug intelligence / Profile preview

triamcinolone acetonide + nystatin + gramicidin

Development stage
Unknown
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

A topical combination drug that contains **triamcinolone acetonide** (a synthetic corticosteroid with anti-inflammatory and antipruritic effects), **nystatin** (an antifungal polyene that binds to ergosterol in fungal cell membranes, causing increased permeability and cell death), and **gramicidin** (a peptide antibiotic active against gram-positive bacteria by increasing membrane permeability). This combination is used primarily for corticosteroid-responsive skin conditions complicated by secondary bacterial and fungal infections. It acts by reducing inflammation and suppressing immune responses (triamcinolone acetonide), directly killing susceptible fungi (nystatin), and eliminating certain bacteria (gramicidin)[4][9][11][12][13].

02

Targets

ErgosterolGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on triamcinolone acetonide + nystatin + gramicidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on triamcinolone acetonide + nystatin + gramicidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call